From January to September 2019, companies in the region bought vaccines for human use abroad for $154 million, 56% more than what was reported for the same period in 2018, a rise that is mainly explained by the behavior of imports in Panama.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphics"]
During the first semester of 2019, companies from Central American countries bought $20 million in vaccines for animal use abroad, and 55% was imported by companies in Guatemala and Costa Rica.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphics"]
In the first half of 2019, purchases of vaccines for human use in Central America totaled $122 million, 116% more than was reported in the same period in 2018.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAPHIC caption="Click to interact with graphic"]
During the first quarter of 2019, companies in Central American countries purchased $8 million in vaccines for animal use abroad, and imports from the U.S. grew 12% over the same period in 2018.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAPHIC caption="Click to interact with graphic"]
In the first quarter of 2019, purchases of vaccines for human use in Central America totaled $66 million, 347% more than was reported in the same period in 2018.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAPHIC caption="Click to interact with graphic"]
During the first nine months of 2018, Central American countries purchased $32 million in vaccines for animal use abroad, 17% more than in the same period in 2017.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphics]
In the first nine months of 2018, purchases of vaccines for human use in Central America totaled $99 million, and imports from India grew 72% over the same period in 2017.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
During the first six months of the year, Central American countries purchased $22 million in vaccines for animal use abroad, 26% more than in the same period in 2017.
Figures from the information system of the Vaccine Market for Veterinary Use in Central America, compiled by the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
Notwithstanding the economic uncertainty in Costa Rica, businessmen in the pet care and attention sector maintain positive expectations in the short and medium term.
The high fiscal deficit and the depreciation of the local currency, that has accelerated in the last two months, are some of the issues that have generated uncertainty in several productive sectors of the country. However, companies engaged in the production of different types of articles for pets and the care of domestic animals, expect that sales levels will remain stable in the future or increase in the best of the situations.
During the first half of the year, purchases of vaccines for human use in Central America totaled $57 million, and imports from France increased 83% over the same period in 2017.
Figures from the information system Vaccine Market for Human Use in Central America, from the Trade Intelligence Area of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
During the first three months of the year, countries in the region bought $9.3 million worth of vaccines for animal use from abroad, 5% more than was registered in the same period in 2017.
Figures from the information system of the Vaccine Market for Veterinary Use in Central America, compiled by the Business Intelligence Unit at CentralAmericaData: [GRAFICA caption = "Click to interact with graph"]
In the first quarter of the year, companies in the country imported $2.1 million worth of vaccines for human use, and 88% was purchased from France and Panama.
Figures from the information system on the Vaccine Market for Human Use in Central America, compiled by the Business Intelligence Unit at CentralAmericaData: [GRAFICA caption = "Click to interact with graph"]
In the first quarter of the year, purchases of vaccines for human use in Central America totaled $15 million, and 48% were imported from India, France and Belgium.
Figures from the information system on the Vaccine Market for Human Use in Central America, compiled by the Business Intelligence Unit at CentralAmericaData: [GRAFICA caption = "Click to interact with graph"]
Operating Company dedicated to the manufacture of gluten-free and sugar-free products, OHNE brand. The OHNE brand has 8 product lines: square bread, sweet...
Has everything. Ocean views, waterfalls, 20 titled building sites, profits, end of the road privacy but close to everything. Less than an hour to shopping, medical services, beaches, airport. Spring and summer all year, in the 70s – 80s, fresh...
español
2114